Integrins and p53 pathways in glioblastoma resistance to temozolomide

Glioblastoma is the most common malignant primary brain tumor. Surgical resection, postoperative radiotherapy plus concomitant and adjuvant chemotherapy with temozolomide (TMZ) is the standard of care for newly diagnosed glioblastoma. In the past decade, efforts have been made to decipher genomic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Sophie, Janouskova, Hana, Dontenwill, Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484330/
https://www.ncbi.nlm.nih.gov/pubmed/23120745
http://dx.doi.org/10.3389/fonc.2012.00157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484330/
https://www.ncbi.nlm.nih.gov/pubmed/23120745
http://dx.doi.org/10.3389/fonc.2012.00157

Ejemplares similares